menu search

Paxmedica’s research on low dose suramin for autism spectrum disorder accepted for publication

TARRYTOWN, N.Y. , Oct. 26, 2023 (GLOBE NEWSWIRE) — via IBN — PaxMedica, Inc. (Nasdaq: PXMD) a clinical-stage bio...

October 26, 2023, 5:51 pm

West pharmaceutical services, inc. (wst) q3 2023 earnings call transcript

West pharmaceutical Services, Inc. (NYSE:WST ) Q3 2023 Earnings Conference Call October 26, 2023 9:00 A...

October 26, 2023, 3:50 pm

Lgnd vs. ilmn: which stock is the better value option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Ligand ...

October 26, 2023, 12:47 pm

Jazz vs. zts: which stock is the better value option?

Investors with an interest in Medical - Drugs stocks have likely encountered both Jazz pharmaceuticals ...

October 26, 2023, 12:47 pm

This market-beating growth stock is set to outperform yet again in 2024

Large-cap growth stocks with wide economic moats and top-shelf management teams have outperformed this year. Vertex ...

October 26, 2023, 10:00 am

Why is theratechnologies (thtx) stock down 22% today?

Theratechnologies (NASDAQ: THTX ) stock is dropping on Thursday after the biopharmaceutical company an...

October 26, 2023, 9:11 am

West pharmaceutical services (wst) q3 earnings and revenues beat estimates

West pharmaceutical Services (WST) came out with quarterly earnings of $2.16 per share, beating the Zac...

October 26, 2023, 8:16 am

Medical equipment maker west pharmaceutical raises 2023 profit forecast

Medical equipment maker West pharmaceutical Services on Thursday raised its 2023 adjusted profit foreca...

October 26, 2023, 6:40 am

Japan's takeda slashes full-year profit forecast on drug pipeline impairments

Japan's biggest drugmaker Takeda pharmaceutical on Thursday slashed its full-year profit forecast by 36...

October 26, 2023, 2:06 am

Zoetis: significant capex investments for long-term growth, but a hold now

Zoetis is an animal health company specializing in the development and manufacturing of veterinary pharmaceuti...

October 26, 2023, 1:18 am

Supernus pharmaceuticals to announce third quarter 2023 financial results and host conference call on november 8, 2023

ROCKVILLE, Md., Oct. 25, 2023 (GLOBE NEWSWIRE) — Supernus pharmaceuticals, Inc. (Nasdaq: SUPN), a bio...

October 25, 2023, 8:15 pm

2 fast dividend growers with strong outlooks

Broadcom Inc. and Perrigo Company plc are two companies providing impressive dividend growth to their shareholders. Perrigo Company is a smaller ...

October 25, 2023, 2:46 pm

Reneo pharmaceuticals announces poster presentation at upcoming scientific meetings

IRVINE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Reneo pharmaceuticals, Inc. (NASDAQ: RPHM), a clinic...

October 25, 2023, 11:50 am

Are medical stocks lagging amneal pharmaceuticals (amrx) this year?

Here is how Amneal pharmaceuticals (AMRX) and KalVista pharmace...

October 25, 2023, 11:22 am

Ani pharmaceuticals to discuss third quarter 2023 financial results on november 8, 2023, at 8:30 a.m. et

BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) — ANI pharmaceuticals, Inc. (“ANI” or the “Comp...

October 25, 2023, 10:50 am

Why is bioxcel therapeutics (btai) stock up 42% today?

BioXcel Therapeutics (NASDAQ: BTAI ) stock is rocketing higher on Wednesday after the biopharmaceutical...

October 25, 2023, 9:18 am

Carisma to present first results from in vivo car-m collaboration with moderna at sitc 2023

-Late-breaking abstract to be presented on November 3 rd at 11:30 am PT highlighting pre-clinical data with Moderna -Two additional pre-clinical data ...

October 25, 2023, 9:11 am

Why is inmed pharmaceuticals (inm) stock down 25% today?

InMed pharmaceuticals (NASDAQ: INM ) stock is falling on Wednesday after the ...

October 25, 2023, 9:00 am

Phathom pharmaceuticals to participate in upcoming investor conferences

FLORHAM PARK, N.J., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Phathom pharmaceuticals, Inc. (Nasdaq: PHAT), a b...

October 25, 2023, 8:01 am

Fate therapeutics to webcast conference call reporting third quarter 2023 financial results

SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...

October 25, 2023, 8:00 am


Search within

Pages Search Results: